title: Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia.
authors.forename: R A
authors.initials: RA
authors.lastname: Clift
authors.forename: J
authors.initials: J
authors.lastname: Radich
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: P
authors.initials: P
authors.lastname: Martin
authors.forename: M E
authors.initials: ME
authors.lastname: Flowers
authors.forename: H J
authors.initials: HJ
authors.lastname: Deeg
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: E D
authors.initials: ED
authors.lastname: Thomas
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D016019:Survival Analysis; D013997:Time Factors; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation
chemical_list: D003520:Cyclophosphamide; D002066:Busulfan